טוען...
Lung cancer incidence and mortality with extended follow-up in the National LungScreening Trial
The extended follow-up of the NLST represents a timely and important update to the NLST data, alongside full results of the NELSON and the LUSI trials, as Europe begins to set out a vision for lung cancer screening. http://bit.ly/2MYXedI
שמור ב:
| הוצא לאור ב: | Breathe (Sheff) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Respiratory Society
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7078741/ https://ncbi.nlm.nih.gov/pubmed/32194768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0322-2019 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|